BRCA1 and cancer: We suggest employing High-Resolution Melting Curve (HRM) real-time PCR as an affordable method to validate the extremely frequent pathogenic BRCA1/2 mutations in the most impacted exons in the blood of Egyptian CRC patients and their families as a non-invasive sample for cancer screening.